Gem Aromatics Limited (NSE:GEMAROMA)
India
· Delayed Price · Currency is INR 166.62
-2.74 (-1.62%)
Apr 29, 2026, 3:29 PM IST
Gem Aromatics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 4,583 | 5,040 | 4,525 | 4,248 | 3,420 | 3,059 |
| Revenue Growth (YoY) | - | 11.38% | 6.51% | 24.22% | 11.79% | - |
| Cost of Revenue | 3,472 | 3,771 | 3,416 | 3,178 | 2,570 | 2,508 |
| Gross Profit | 1,110 | 1,268 | 1,108 | 1,070 | 850.09 | 550.85 |
| Selling, General & Admin | 137.23 | 128.27 | 111.34 | 108.07 | 97.47 | 73.66 |
| Other Operating Expenses | 265.02 | 255.02 | 212.3 | 253.35 | 184.24 | 167.63 |
| Operating Expenses | 557.25 | 456.71 | 386.27 | 409 | 320.46 | 274.02 |
| Operating Income | 553.21 | 811.48 | 721.93 | 660.92 | 529.63 | 276.83 |
| Interest Expense | -128.34 | -78.8 | -60.78 | -50.73 | -25.42 | -18.77 |
| Interest & Investment Income | 7.5 | 7.5 | 7.85 | 0.22 | 0.07 | 1.04 |
| Currency Exchange Gain (Loss) | -0.38 | -0.38 | -1.19 | -46.43 | 24.39 | 43.42 |
| Other Non Operating Income (Expenses) | -9.77 | 5.47 | 7.44 | -3.49 | -2.65 | -2.23 |
| EBT Excluding Unusual Items | 422.22 | 745.27 | 675.25 | 560.49 | 526.02 | 300.29 |
| Gain (Loss) on Sale of Assets | 0.83 | 0.83 | -0.04 | 0.06 | 0.28 | 0.08 |
| Other Unusual Items | 1.05 | 1.05 | 0.52 | 0.54 | - | - |
| Pretax Income | 424.1 | 747.15 | 675.73 | 561.09 | 526.31 | 300.36 |
| Income Tax Expense | 143.94 | 213.31 | 174.9 | 114.17 | 129.74 | 68.44 |
| Net Income | 280.16 | 533.84 | 500.83 | 446.92 | 396.57 | 231.92 |
| Net Income to Common | 280.16 | 533.84 | 500.83 | 446.92 | 396.57 | 231.92 |
| Net Income Growth | - | 6.59% | 12.06% | 12.70% | 70.99% | - |
| Shares Outstanding (Basic) | 50 | 47 | 47 | 47 | 2 | 2 |
| Shares Outstanding (Diluted) | 50 | 47 | 47 | 47 | 2 | 2 |
| Shares Change (YoY) | 7.10% | - | - | 2525.00% | - | - |
| EPS (Basic) | 5.58 | 11.39 | 10.69 | 9.54 | 222.19 | 129.94 |
| EPS (Diluted) | 5.57 | 11.39 | 10.69 | 9.54 | 222.19 | 129.94 |
| EPS Growth | - | 6.55% | 12.06% | -95.71% | 70.99% | - |
| Free Cash Flow | - | -1,300 | 9.79 | 8.34 | -229.46 | -57.85 |
| Free Cash Flow Per Share | - | -27.75 | 0.21 | 0.18 | -128.56 | -32.41 |
| Gross Margin | 24.23% | 25.16% | 24.49% | 25.19% | 24.86% | 18.01% |
| Operating Margin | 12.07% | 16.10% | 15.96% | 15.56% | 15.49% | 9.05% |
| Profit Margin | 6.11% | 10.59% | 11.07% | 10.52% | 11.60% | 7.58% |
| Free Cash Flow Margin | - | -25.80% | 0.22% | 0.20% | -6.71% | -1.89% |
| EBITDA | 627.88 | 878.39 | 778.5 | 703.49 | 568 | 309.57 |
| EBITDA Margin | 13.70% | 17.43% | 17.21% | 16.56% | 16.61% | 10.12% |
| D&A For EBITDA | 74.67 | 66.91 | 56.57 | 42.57 | 38.38 | 32.74 |
| EBIT | 553.21 | 811.48 | 721.93 | 660.92 | 529.63 | 276.83 |
| EBIT Margin | 12.07% | 16.10% | 15.96% | 15.56% | 15.49% | 9.05% |
| Effective Tax Rate | 33.94% | 28.55% | 25.88% | 20.35% | 24.65% | 22.79% |
| Revenue as Reported | 4,584 | 5,056 | 4,542 | 4,251 | 3,446 | 3,104 |
Source: S&P Capital IQ. Standard template. Financial Sources.